Huadong Medicine Co (SZSE:000963) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Change In Receivables?

Huadong Medicine Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Huadong Medicine Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Huadong Medicine Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-969 Mil. It means Huadong Medicine Co's Accounts Receivable increased by ¥969 Mil from Dec. 2022 to Dec. 2023 .

Huadong Medicine Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥9,678 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Huadong Medicine Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 84.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Huadong Medicine Co's liquidation value for the three months ended in Mar. 2024 was ¥953 Mil.

Huadong Medicine Co Change In Receivables Historical Data

The historical data trend for Huadong Medicine Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Change In Receivables Chart

Huadong Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-815.96

-530.30

-775.57

-2,095.11

-968.97

Huadong Medicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Huadong Medicine Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Huadong Medicine Co (SZSE:000963) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Huadong Medicine Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	9677.692	/	10410.809	*	91
=	84.82

2. In Ben Graham's calculation of liquidation value, Huadong Medicine Co's accounts receivable are only considered to be worth 75% of book value:

Huadong Medicine Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3563.065	-	11980.051	+	0.75 * 9677.692	+	0.5 * 4224.075
=	953

Huadong Medicine Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006

Website

http://www.eastchinapharm.com

Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines